Curis
CRIS
#10248
Rank
โ‚น1.24 B
Marketcap
โ‚น96.57
Share price
-6.96%
Change (1 day)
-63.11%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น331.24. In 2024 the company made an earnings per share (EPS) of -โ‚น634.50 an increase over its 2023 EPS that were of -โ‚น815.01.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.21%
2024-โ‚น634.50-22.15%
2023-โ‚น815.01-26.17%
2022-โ‚น1,10422.3%
2021-โ‚น902.56-25.37%
2020-โ‚น1,209-30.93%
2019-โ‚น1,751-2.02%
2018-โ‚น1,787
2016-โ‚น4,062-10%
2015-โ‚น4,513138.1%
2014-โ‚น1,89540%
2013-โ‚น1,354-25%
2012-โ‚น1,80566.67%
2011-โ‚น1,083

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น214.81-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น127.26-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.49-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น305.06-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.24-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น268.06-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,014 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA